BPC-157 5mg, TB-500 5mg (Blend)

This dual-peptide formulation combines BPC-157, a synthetic gastric pentadecapeptide, with TB-500 (a synthetic fragment of Thymosin Beta-4), both of which have been extensively studied in preclinical models for their potential roles in tissue health and cellular activity.

Key Research Characteristics:

• BPC-157 – Investigated for its influence on angiogenesis, growth factor modulation, and tissue response in laboratory settings.

• TB-500 – Studied for its effects on cell migration, tissue regeneration, and structural support in preclinical models.

• Designed for research exploring complementary pathways in cellular and tissue-related processes.

• High-purity, research-grade formulation.

Intended Use:
For qualified research professionals only. All products are intended for laboratory research purposes and are not approved for human use. Not for human consumption, therapeutic, or diagnostic applications.